Address
Rue Edouard Belin 12
Mont-Saint-Guibert, 1435
Belgium
Phone
32 1 022 23 55
Website
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
183
First IPO Date
April 28, 2021
| Name | Title | Pay | Year Born |
| Olivier Taelman | Chief Executive Officer & Executive Director | 1M | 1972 |
| Robert Taub | Co-Founder & Chairman | 136,062 | 1947 |
| Loic Moreau | President of International | 537,865 | 1980 |
| Bruno Onkelinx | Chief Technical Officer | 1.71M | 1972 |
| Jeyakumar Subbaroyan | Chief Science Officer | 0 | N/A |
| John Landry | Chief Financial Officer | 0 | 1973 |
| Geeta Kaveti | Chief Compliance Officer | 0 | N/A |
| Maggie McGowan | Chief HR Officer | 0 | N/A |
| An Moonen | General Counsel | 0 | N/A |
| Pearson Dennis | Investor Relations Associate | 0 | N/A |
Nyxoah S.A. is a medical technology company dedicated to developing and bringing to market therapies for sleep disordered breathing conditions. Its flagship offering is the Genio system, a CE-Marked, patient-focused hypoglossal neurostimulation therapy that addresses moderate to severe obstructive sleep apnea. Established in 2009, the company maintains its headquarters in Mont-Saint-Guibert, Belgium.